These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 26308087)
41. Familial clustering of colon, breast, uterine, and ovarian cancers as assessed by family history. Nelson CL; Sellers TA; Rich SS; Potter JD; McGovern PG; Kushi LH Genet Epidemiol; 1993; 10(4):235-44. PubMed ID: 8224804 [TBL] [Abstract][Full Text] [Related]
42. Risk of thyroid cancer in first-degree relatives of patients with non-medullary thyroid cancer by histology type and age at diagnosis: a joint study from five Nordic countries. Fallah M; Pukkala E; Tryggvadottir L; Olsen JH; Tretli S; Sundquist K; Hemminki K J Med Genet; 2013 Jun; 50(6):373-82. PubMed ID: 23585692 [TBL] [Abstract][Full Text] [Related]
43. Informing relatives about their hereditary or familial cancer risk: study protocol for a randomized controlled trial. de Geus E; Aalfs CM; Verdam MG; de Haes HC; Smets EM Trials; 2014 Mar; 15():86. PubMed ID: 24649895 [TBL] [Abstract][Full Text] [Related]
44. Cancer disclosure: experiences of Iranian cancer patients. Valizadeh L; Zamanzadeh V; Rahmani A; Howard F; Nikanfar AR; Ferguson C Nurs Health Sci; 2012 Jun; 14(2):250-6. PubMed ID: 22462718 [TBL] [Abstract][Full Text] [Related]
45. Familial history of cancer and childhood acute leukemia: a French population-based case-control study. Ripert M; Menegaux F; Perel Y; Méchinaud F; Plouvier E; Gandemer V; Lutz P; Vannier JP; Lamagnére JP; Margueritte G; Boutard P; Robert A; Armari-Alla C; Munzer M; Millot F; de Lumley L; Berthou C; Rialland X; Pautard B; Clavel J Eur J Cancer Prev; 2007 Oct; 16(5):466-70. PubMed ID: 17923819 [TBL] [Abstract][Full Text] [Related]
46. High prevalence and familial aggregation of keratoconus in an Iranian rural population: a population-based study. Hashemi H; Heydarian S; Yekta A; Ostadimoghaddam H; Aghamirsalim M; Derakhshan A; Khabazkhoob M Ophthalmic Physiol Opt; 2018 Jul; 38(4):447-455. PubMed ID: 29572900 [TBL] [Abstract][Full Text] [Related]
47. Family history of cancer and the risk of childhood brain tumors: a pooled analysis of the ESCALE and ESTELLE studies (SFCE). Vidart d'Egurbide Bagazgoïtia N; Bailey HD; Orsi L; Guerrini-Rousseau L; Bertozzi AI; Faure-Conter C; Leblond P; Pellier I; Freycon C; Doz F; Puget S; Ducassou S; Lacour B; Clavel J Cancer Causes Control; 2019 Oct; 30(10):1075-1085. PubMed ID: 31399828 [TBL] [Abstract][Full Text] [Related]
48. Family history of breast, ovarian and endometrial cancer and risk of breast cancer. Parazzini F; La Vecchia C; Negri E; Franceschi S; Tozzi L Int J Epidemiol; 1993 Aug; 22(4):614-8. PubMed ID: 8225733 [TBL] [Abstract][Full Text] [Related]
49. The big reveal: Family disclosure patterns of BRCA genetic test results among young Black women with invasive breast cancer. Conley CC; Ketcher D; Reblin M; Kasting ML; Cragun D; Kim J; Ashing KT; Knott CL; Hughes-Halbert C; Pal T; Vadaparampil ST J Genet Couns; 2020 Jun; 29(3):410-422. PubMed ID: 31912597 [TBL] [Abstract][Full Text] [Related]
50. Increasing prevalence of familial recurrence of multiple sclerosis in Iran: a population based study of Tehran registry 1999-2015. Eskandarieh S; Allahabadi NS; Sadeghi M; Sahraian MA BMC Neurol; 2018 Feb; 18(1):15. PubMed ID: 29415659 [TBL] [Abstract][Full Text] [Related]
51. Comparison of self-reported and database-linked family history of cancer data in a case-control study. Kerber RA; Slattery ML Am J Epidemiol; 1997 Aug; 146(3):244-8. PubMed ID: 9247008 [TBL] [Abstract][Full Text] [Related]
52. Familial aggregation of urothelial cell carcinoma. Aben KK; Witjes JA; Schoenberg MP; Hulsbergen-van de Kaa C; Verbeek AL; Kiemeney LA Int J Cancer; 2002 Mar; 98(2):274-8. PubMed ID: 11857419 [TBL] [Abstract][Full Text] [Related]
53. How to support cancer genetics counselees in informing at-risk relatives? Lessons from a randomized controlled trial. Eijzenga W; de Geus E; Aalfs CM; Menko FH; Sijmons RH; de Haes HCJM; Smets EMA Patient Educ Couns; 2018 Sep; 101(9):1611-1619. PubMed ID: 29789176 [TBL] [Abstract][Full Text] [Related]
54. Excess breast cancer risk in first degree relatives of CHEK2∗1100delC positive familial breast cancer cases. Adank MA; Verhoef S; Oldenburg RA; Schmidt MK; Hooning MJ; Martens JW; Broeks A; Rookus M; Waisfisz Q; Witte BI; Jonker MA; Meijers-Heijboer H Eur J Cancer; 2013 May; 49(8):1993-9. PubMed ID: 23415889 [TBL] [Abstract][Full Text] [Related]
55. Familial breast cancer: collaborative reanalysis of individual data from 52 epidemiological studies including 58,209 women with breast cancer and 101,986 women without the disease. Collaborative Group on Hormonal Factors in Breast Cancer Lancet; 2001 Oct; 358(9291):1389-99. PubMed ID: 11705483 [TBL] [Abstract][Full Text] [Related]
56. Prevalence and Correlates of Family Cancer History Knowledge and Communication Among US Adults. Krakow M; Rising CJ; Trivedi N; Yoon DC; Vanderpool RC Prev Chronic Dis; 2020 Nov; 17():E146. PubMed ID: 33211995 [TBL] [Abstract][Full Text] [Related]
57. Familial history of esophageal cancer. Ghadirian P Cancer; 1985 Oct; 56(8):2112-6. PubMed ID: 4027937 [TBL] [Abstract][Full Text] [Related]
58. An analytical method for assessing patterns of familial aggregation in case-control studies. Zhao LP; Le Marchand L Genet Epidemiol; 1992; 9(2):141-54. PubMed ID: 1639245 [TBL] [Abstract][Full Text] [Related]
59. Determinants of undisclosed HIV status to a community-based HIV program: findings from caregivers of orphans and vulnerable children in Tanzania. Charles J; Exavery A; Barankena A; Kuhlik E; Mubyazi GM; Abdul R; Koler A; Kikoyo L; Jere E AIDS Res Ther; 2020 Jul; 17(1):42. PubMed ID: 32678036 [TBL] [Abstract][Full Text] [Related]
60. Patients' intentions to inform relatives about Type 2 diabetes risk: the role of worry in the process of family risk disclosure. van Esch SC; Nijkamp MD; Cornel MC; Snoek FJ Diabet Med; 2012 Dec; 29(12):e461-7. PubMed ID: 23003196 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]